Tracers for management of melanoma
Custom microchips
New fluorinated amino acid tracer
Hybrid X-ray detector
CRCBID is researching tracers that are potentially very useful for clinical management of melanoma...read more
Custom microchips designed by MCSS/CRCBID employ circuitry capable of energy resolving and photon counting X-rays....read more
A new fluorinated amino acid tracer derivative of methionine has recently been developed by CRCBID researchers...read more
Research team members from MCSS recently conducted a 24 hour run on the Australian synchrotron...read more
The CRC for Biomedical Imaging Development (CRCBID) is a leading edge Australian research company that works with industry and research partners to develop high-specificity imaging radiopharmaceuticals and high-sensitivity detectors for positron emission tomography (PET) and other medical and industrial imaging applications.
CRCBID is established and supported under the Australian Government’s Cooperative Research Centre (CRC) program.
|
© Copyright 2010 - CRC for Biomedical Imaging Development Ltd
(ABN 33 115 962 386) 40 Clements Avenue
Bundoora Victoria 3083 Australia Tel: +613 9467 6277 Fax: +613 9467 7493 home | privacy | login | solution by getsetfor.com |
 |